204 related articles for article (PubMed ID: 15386713)
1. Use and adherence to beta-blockers for secondary prevention of myocardial infarction: who is not getting the treatment?
Wei L; Flynn R; Murray GD; MacDonald TM
Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):761-6. PubMed ID: 15386713
[TBL] [Abstract][Full Text] [Related]
2. Beta-blocker underuse in secondary prevention of myocardial infarction.
Everly MJ; Heaton PC; Cluxton RJ
Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
[TBL] [Abstract][Full Text] [Related]
3. Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction.
Andersen SS; Hansen ML; Gislason GH; Folke F; Schramm TK; Fosbøl E; Sørensen R; Rasmussen S; Abildstrøm SZ; Madsen M; Køber L; Torp-Pedersen C
Cardiology; 2009; 112(2):144-50. PubMed ID: 18612201
[TBL] [Abstract][Full Text] [Related]
4. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
5. Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario.
Rochon PA; Anderson GM; Tu JV; Clark JP; Gurwitz JH; Szalai JP; Lau P
CMAJ; 1999 Nov; 161(11):1403-8. PubMed ID: 10906894
[TBL] [Abstract][Full Text] [Related]
6. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction.
Smith DH; Kramer JM; Perrin N; Platt R; Roblin DW; Lane K; Goodman M; Nelson WW; Yang X; Soumerai SB
Arch Intern Med; 2008 Mar; 168(5):477-83; discussion 483; quiz 447. PubMed ID: 18332291
[TBL] [Abstract][Full Text] [Related]
8. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
9. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
Fernandes AW; Madhavan SS; Amonkar MM
Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
[TBL] [Abstract][Full Text] [Related]
11. Beta-blocker compliance, mortality, and reinfarction: validation of clinical trial association using insurer claims data.
Kleiner SA; Vogt WB; Gladowski P; DeVries A; Levin G; Antonucci C; Fong J
Am J Med Qual; 2009; 24(6):512-9. PubMed ID: 19890140
[TBL] [Abstract][Full Text] [Related]
12. The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade.
Lindenauer PK; Fitzgerald J; Hoople N; Benjamin EM
Arch Intern Med; 2004 Apr; 164(7):762-6. PubMed ID: 15078646
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
[TBL] [Abstract][Full Text] [Related]
14. The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group.
Eur Heart J; 1988 Jan; 9(1):8-16. PubMed ID: 2894312
[TBL] [Abstract][Full Text] [Related]
15. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance.
Kramer JM; Hammill B; Anstrom KJ; Fetterolf D; Snyder R; Charde JP; Hoffman BS; Allen LaPointe N; Peterson E
Am Heart J; 2006 Sep; 152(3):454.e1-8. PubMed ID: 16923412
[TBL] [Abstract][Full Text] [Related]
16. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
[TBL] [Abstract][Full Text] [Related]
17. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use.
Dattilo PB; Hailpern SM; Fearon K; Sohal D; Nordin C
Ann Emerg Med; 2008 Feb; 51(2):117-25. PubMed ID: 17583376
[TBL] [Abstract][Full Text] [Related]
18. Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy.
O'Connor CM; Gottlieb S; Bourque JM; Krause-Steinrauf H; Anand I; Anderson JL; Plehn JF; Silver MA; White M; Carson P;
Am J Cardiol; 2005 Mar; 95(5):558-64. PubMed ID: 15721091
[TBL] [Abstract][Full Text] [Related]
19. Association of beta-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS).
Chan JD; Rea TD; Smith NL; Siscovick D; Heckbert SR; Lumley T; Chaves P; Furberg CD; Kuller L; Psaty BM
Am Heart J; 2005 Sep; 150(3):464-70. PubMed ID: 16169325
[TBL] [Abstract][Full Text] [Related]
20. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
